[STUDIES ON THE TREATMENT OF ENDOGENOUS  HYPERLIPOPROTEINEMIA WITH BETA-PYRIDYL-CARBINOL].
D006801:Humans; D006937:Hypercholesterolemia; D006949:Hyperlipidemias; D006951:Hyperlipoproteinemias; D008074:Lipoproteins; D000432:Methanol; D009525:Niacin; D009539:Nicotinic Acids; D009540:Nicotinyl Alcohol; D011725:Pyridines; D014665:Vasodilator Agents
D008074:Lipoproteins; D009539:Nicotinic Acids; D011725:Pyridines; D014665:Vasodilator Agents; D009525:Niacin; D009540:Nicotinyl Alcohol; D000432:Methanol
HYPERCHOLESTEREMIA; HYPERLIPEMIA; LIPOPROTEINS; NICOTINIC ACID; PYRIDINES; VASODILATOR AGENTS
UNTERSUCHUNGEN ZUR BEHANDLUNG DER ENDOGENEN HYPERLIPOPROTEIDAEMIE MIT BETA-PYRIDYL-CARBINOL.